300725.SZ实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:04):

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production...

Stats
今日成交量	7.13M
平均成交量	7.36M
市值	6.58B
EPS	CNY0.199 ( 2023-10-30 )
下一个收益日期	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	35.52
ATR14	CNY0.0670 (0.20%)

音量相关性

長: 0.33 (neutral)

短: -0.35 (neutral)

Signal:(55.777) Neutral

PharmaBlock Sciences 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PharmaBlock Sciences 相关性 - 货币/商品

0.12
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.05
( neutral )

0.11
( neutral )

-0.25
( neutral )

PharmaBlock Sciences 财务报表

Annual	2023
营收:	CNY1.71B
毛利润:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2023
营收:	CNY1.71B
毛利润:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2022
营收:	CNY1.59B
毛利润:	CNY725.20M (45.48 %)
EPS:	CNY1.570

FY	2021
营收:	CNY1.20B
毛利润:	CNY578.29M (48.13 %)
EPS:	CNY2.46

Financial Reports:

No articles found.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.